Dr. Antonella Lisi is a Senior Research Scientist and Laboratory Manager at the Institute of Translational Pharmacology (IFT) of the National Research Council (CNR), Rome, Italy. She holds a Master's Degree in Biological Science and a PhD in Clinical Pathology.  Dr. Lisi’s basic research interests focus on Regenerative Medicine: Tissue Engineering and Cellular Therapies, the study of differentiation processes induced by chemical and/or physical agents on mesenchymal, cardiac and hepatic stem cells; Biomaterials and Nanobiotechnologies: study of biocompatibility and the interaction effects between nanobiomaterials and biological systems; Characterization and study of the growth, proliferation and differentiation processes of stem cells on nanostructured supports. Author of over 90 peer-reviewed scientific articles published in international journals and several book chapters. She is also the inventor of five patents and a reviewer of scientific articles published in international journals ISI I.F. Furthermore, Dr. Lisi has been an expert evaluator for scientific projects of the European Commission, the University of Insubria and the University of Toulouse since 2014.